[1] Hernando V, Alejos B, Alvarez D, et al. Reproductive desire in women with HIV infection in Spain, associated factors and motivations:a mixed-method study. BMC Pregnancy Childbirth, 2014; 14, 194. doi:  10.1186/1471-2393-14-194
[2] John GC, Kreiss J. Mother-to-child transmission of human immunodeficiency virus type 1. Epidemiol Rev, 1996; 18, 149-57. doi:  10.1093/oxfordjournals.epirev.a017922
[3] Fasawe O, Avila C, Shaffer N, et al. Cost-effectiveness analysis of Option B+ for HIV prevention and treatment of mothers and children in Malawi. PLoS One, 2013; 8, e57778. doi:  10.1371/journal.pone.0057778
[4] WHO, The Alan Guttmacher Institute (AGI)-World Health Organization (WHO) Facts on induced abortion worldwide. http://www.who.int/reproductivehealth/publications/unsafe_abortion/induced_abortion_2012.pdf.[2017-11-15]
[5] Orner PJ, de Bruyn M, Barbosa RM, et al. Access to safe abortion:building choices for women living with HIV and AIDS. J Int AIDS Soc, 2011; 14, 54. doi:  10.1186/1758-2652-14-54
[6] Pilecco FB, Teixeira LB, Vigo A, et al. Lifetime induced abortion:a comparison between women living and not living with HIV. PLoS One, 2014; 9, e95570. doi:  10.1371/journal.pone.0095570
[7] Orner P, M de Bruyn, J Harries, et al. A qualitative exploration of HIV-positive pregnant women's decision-making regarding abortion in Cape Town, South Africa. SAHARA J, 2010; 7, 44-51.
[8] Marseille E, JG Kahn, J Saba. Cost-effectiveness of antiviral drug therapy to reduce mother-to-child HIV transmission in sub-Saharan Africa. AIDS, 1998; 12, 939-48. doi:  10.1097/00002030-199808000-00017
[9] The World Bank. World Bank national accounts data, and OECD National Accounts data files (in 2016). https://data.worldbank.org/indicator/NY.GDP.PCAP.CD.[2017-12-27].
[10] Mohamed SF, C Izugbara, AM Moore, et al. The estimated incidence of induced abortion in Kenya:a cross-sectional study. BMC Pregnancy Childbirth, 2015; 15, 185. doi:  10.1186/s12884-015-0621-1
[11] Initiative, CHA. 2016 ANTIRETROVIRAL (ARV) CHAI REFERENCE PRICE LIST. https://clintonhealthaccess.org/content/uploads/2016/11/2016-CHAI-ARV-Reference-Price-List_FINAL.pdf.[2017-12-25].
[12] Chaibakhsh S. PMTCT and Pediatrics Impact & Cost Model. International AIDS Society Conference, July 2011, Rome, Italy.
[13] Barker P, P Barron, S Bhardwaj, et al. The role of quality improvement in achieving effective large-scale prevention of mother-to-child transmission of HIV in South Africa. AIDS, 2015; 29, S137-43. doi:  10.1097/QAD.0000000000000718
[14] Sherman GG, RR Lilian, S Bhardwaj, et al. Laboratory information system data demonstrate successful implementation of the prevention of mother-to-child transmission programme in South Africa. S Afr Med J, 2014; 104, 235-8. doi:  10.7196/SAMJ.7598
[15] Ashiono E, D Achwoka, J Mutugi, et al. Vertical HIV transmission in perinatally-exposed infants in South-Rift region of Kenya:a retrospective cross sectional study. BMC Public Health, 2017; 17, 207. doi:  10.1186/s12889-017-4124-z
[16] Nguyen TTV, K Sabin, TQT Ho, et al. Monitoring Prevention Impact of Mother-to-Child Transmission of HIV in Concentrated Epidemics With Program and Survey Data. JMIR Public Health Surveill, 2017; 3, e76. doi:  10.2196/publichealth.7701
[17] Ishikawa N, S Dalal, C Johnson, et al. Should HIV testing for all pregnant women continue? Cost-effectiveness of universal antenatal testing compared to focused approaches across high to very low HIV prevalence settings. J Int AIDS Soc, 2016; 19, 21212. doi:  10.7448/IAS.19.1.21212
[18] WHO, Prevention of mother-to-child transmission Data by country. http://apps.who.int/gho/data/node.main.627?lang=en.[2017-12-2].
[19] Clinton Health Access Initiative. Clinton Health Access Initiative-Antiretroviral (ARV) Ceiling Price. http://d2pd3b5abq75bb.cloudfront.net/2012/07/12/15/03/07/163/CHAI_ARV_Ceiling_Price_List_May_2012.pdf.[2017-12-25].
[20] Bello B, D Kielkowski, D Heederik, et al. Time-to-pregnancy and pregnancy outcomes in a South African population. BMC Public Health, 2010; 10, 565. doi:  10.1186/1471-2458-10-565
[21] Nguyen DT, K. N. Vietnam abortion situation country report. Presented at: Advancing the role of mid-level providers in menstrual regulation and elective abortion care. Ipas, Karolinska Institute Division of International Health, Johannesburg. 2-6 December 2001.
[22] WHO, Healthy life expectancy (HALE) Data by country. http://apps.who.int/gho/data/node.main.HALE?lang=en[2017-12-25].
[23] Tweya H, O Keiser, AD Haas, et al. Comparative cost-effectiveness of Option B+ for prevention of mother-to-child transmission of HIV in Malawi:Mathematical modelling study. AIDS, 2016; 30, 953-62. doi:  10.1097/QAD.0000000000001009